RRx-001 Completed Phase 2 Trials for Colorectal Neoplasms Treatment

Back to RRx-001
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02096354
A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer